Analysis of the costs and reach of transportation services to reduce barriers to opioid use disorder (OUD) treatment: evidence from the Kentucky HEALing Communities Study
4 affiliations
- 1Substance Use Priority Research Area, University of Kentucky
- 2College of Public Health, University of Kentucky
- 3Department of Public Health Sciences, University of Miami Miller School of Medicine
- 4Department of Behavioral Science, University of Kentucky
Abstract
Background Medications for opioid use disorder (MOUD) have been proven to be the most effective method for treating individuals with opioid use disorder (OUD). Individuals who are retained on methadone and buprenorphine treatment have a decreased risk of mortality when compared to others with OUD. However, many individuals in need of MOUD face transportation barriers that prevent them from having the requisite access to treatment. Methods As part of the evidence-based practices (EBPs) implemented throughout the HEALing (Helping to End Addiction Long-term®) Communities Study (HCS), strategies to reduce transportation barriers to receiving methadone and buprenorphine at partner organizations were identified and implemented. Multiple strategies were employed including transportation agency contracts, bus passes, rideshare services, leased agency vans, and fuel cards. This study provides a description of the number of unique riders, including demographic and geographic characteristics, and the costs of providing these transportation services across participating counties. Results Throughout 2023, we partnered with thirty agencies across eight counties to administer $437,481.69 in transportation support services to 7,923 individuals. These services were distributed primarily to individuals who were white (81.8%; 6,483), female (51.9%; 4,112) and between the ages of 35–54 (59.8%; 4,737). The number of individuals reached and expenses were largest among the five urban counties (5,999; $318,317.15), which averaged $53.06 per person. Within the five urban counties, we worked with 23 agency partners and the average agency costs were $10,993.72. Across the three rural counties, costs averaged $61.94 per person reached (1,924; $119,164.54). Among the seven agency partners across the three rural counties, average agency costs were $9,235.38. Conclusions By gaining an understanding of the populations benefiting from these services, breadth of services provided, and the costs required to address this barrier to care, we may more effectively inform decision-makers on the resources needed to link and retain individuals in treatment. Trial registration ClinicalTrials.gov, NCT04111939. Registered 30 September 2019, https://www.clinicaltrials.gov/ct2/show/NCT04111939 .
Related
- Patients' experiences of and adherence to supervised high-intensity physical training integrated into specialised treatment for substance use disorders: study protocol for a qualitative collaborative health services study of facilitators and barriers.
- Barriers to substance use disorder treatment among Asian Americans in New York City: A qualitative study of provider perspectives
- Integrating carers’ experiences and barriers to treatment from ANZAED Credentialed Eating Disorder Clinicians and non-credentialed clinicians in Australia
- Attention-Deficit/Hyperactivity Disorder Treatment Pattern and Its Associated Outcomes Among Children Referred to Psychiatry and Mental Health Services in Malaysia: Protocol for a Retrospective Cohort Study.
- A decade of implementing comprehensive child development services in Northwest Iran: a qualitative study of provider perspectives on barriers and facilitators
BibTeX
@article{speer2026analysis,
title = {{Analysis of the costs and reach of transportation services to reduce barriers to opioid use disorder (OUD) treatment: evidence from the Kentucky HEALing Communities Study}},
author = {Drew D. Speer and Joshua L. Bush and Don Lochana Ekanayake and Julie Nakayima and Michael M. Goetz and Jennifer Miles and Elizabeth Larimore and Hannah K. Knudsen and Sharon L. Walsh and Kathryn E. McCollister},
journal = {Addiction Science \& Clinical Practice},
year = {2026},
month = jul,
doi = {10.1186/s13722-026-00702-1},
url = {https://doi.org/10.1186/s13722-026-00702-1},
note = {CC BY},
}
RIS
TY - JOUR
TI - Analysis of the costs and reach of transportation services to reduce barriers to opioid use disorder (OUD) treatment: evidence from the Kentucky HEALing Communities Study
AU - Drew D. Speer
AU - Joshua L. Bush
AU - Don Lochana Ekanayake
AU - Julie Nakayima
AU - Michael M. Goetz
AU - Jennifer Miles
AU - Elizabeth Larimore
AU - Hannah K. Knudsen
AU - Sharon L. Walsh
AU - Kathryn E. McCollister
PY - 2026
DA - 2026/07/01
JO - Addiction Science & Clinical Practice
DO - 10.1186/s13722-026-00702-1
UR - https://doi.org/10.1186/s13722-026-00702-1
AB - Background Medications for opioid use disorder (MOUD) have been proven to be the most effective method for treating individuals with opioid use disorder (OUD). Individuals who are retained on methadone and buprenorphine treatment have a decreased risk of mortality when compared to others with OUD. However, many individuals in need of MOUD face transportation barriers that prevent them from having the requisite access to treatment. Methods As part of the evidence-based practices (EBPs) implemented throughout the HEALing (Helping to End Addiction Long-term®) Communities Study (HCS), strategies to reduce transportation barriers to receiving methadone and buprenorphine at partner organizations were identified and implemented. Multiple strategies were employed including transportation agency contracts, bus passes, rideshare services, leased agency vans, and fuel cards. This study provides a description of the number of unique riders, including demographic and geographic characteristics, and the costs of providing these transportation services across participating counties. Results Throughout 2023, we partnered with thirty agencies across eight counties to administer $437,481.69 in transportation support services to 7,923 individuals. These services were distributed primarily to individuals who were white (81.8%; 6,483), female (51.9%; 4,112) and between the ages of 35–54 (59.8%; 4,737). The number of individuals reached and expenses were largest among the five urban counties (5,999; $318,317.15), which averaged $53.06 per person. Within the five urban counties, we worked with 23 agency partners and the average agency costs were $10,993.72. Across the three rural counties, costs averaged $61.94 per person reached (1,924; $119,164.54). Among the seven agency partners across the three rural counties, average agency costs were $9,235.38. Conclusions By gaining an understanding of the populations benefiting from these services, breadth of services provided, and the costs required to address this barrier to care, we may more effectively inform decision-makers on the resources needed to link and retain individuals in treatment. Trial registration ClinicalTrials.gov, NCT04111939. Registered 30 September 2019, https://www.clinicaltrials.gov/ct2/show/NCT04111939 .
SN - 1940-0640
SN - 1940-0632
ER -